ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.36
-0.395 (-8.31%)
Last Updated: 12:39:18
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.395 -8.31% 4.36 4.35 4.69 4.75 4.36 4.75 198,046 12:39:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 22676 to 22697 of 99175 messages
Chat Pages: Latest  919  918  917  916  915  914  913  912  911  910  909  908  Older
DateSubjectAuthorDiscuss
20/8/2020
06:38
Check out the news at mgc in oz, phase 2 trials passed on covid treatment
kirk2
20/8/2020
06:09
Beta interferon, an anti-inflammatory drug that has already been approved for treatment of multiple sclerosis, is being paired with remdesivir in the latest phase of a federal coronavirus trial, The New York Times reports. The results of the study's second phase are still being evaluated — and scientists are hopeful. Beta interferon is already on the market, and has shown promise against the new coronavirus, killing it (along with the SARS and MERS coronaviruses) in lab studies. Additionally, tests in the United Kingdom and Hong Kong showed the drug performed better among COVID-19 patients than the placebo it was up against. Both those studies were too small to come away with anything definitive, but the U.S. trial should be large enough to get a better sense of its ability. [The New York Times]
dafad
20/8/2020
05:58
If that is the case then you would think it would be Finn Cap as they are the house broker.Just my opinion
nortic 007
20/8/2020
05:55
It's most likely to be one big trade for a number of different accounts. It's then booked as a lump and then readjusted in checking...... but whatever it is there's a taker at the other side which is good.
nortic 007
20/8/2020
03:46
Sloppy, my target on positive news would be £12- £25 fair value 🚀
strongbuy
19/8/2020
23:23
Not certain, but I suspect we will find out why very soon.
the real capitalcity
19/8/2020
23:12
Anyone suggest why so many 10k(NMS) trades are late reported?
wetdream
19/8/2020
21:43
Stop what? Perfectly reasonable question, surely?
sloppyjoe2
19/8/2020
21:36
Strongbuy - so what's *your* price target short, medium and long-term?
sloppyjoe2
19/8/2020
21:14
Sloppy, they are rockets, this one is going where they go....into orbit 😉🚀🚀🚀 8640;🚀Ԁ77;
strongbuy
19/8/2020
20:31
Strongbuy - I'm on my mobile but I assume those are rockets at the end of your post ;-) Fingers crossed you're right. Bring it on!
sloppyjoe2
19/8/2020
20:30
strongbuy,

Good spot re Phlexglobal.

sikhthetech
Chat Pages: Latest  919  918  917  916  915  914  913  912  911  910  909  908  Older

Your Recent History

Delayed Upgrade Clock